First-Line Pharmacotherapy Approaches for Generalized Anxiety Disorder
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Many patients with generalized anxiety disorder (GAD) do not receive adequate treatment. Several classes of drugs, including benzodiazepines, azapirones, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, antihistamines, alpha(2)delta Ca++ channel modulators, and atypical antipsychotics are consistently beneficial in patients with GAD. Cognitive therapy is also effective as a first-line treatment. When individualizing treatment, drug dose ranges and side effect profiles need to be considered, as well as the patient's comorbid conditions. Doses may need to be reduced for elderly or medically ill patients or those taking other medications. Doses may need to be increased for refractory cases. Common comorbid conditions with GAD include depression, alcohol or drug abuse, social anxiety disorder, and panic disorder. In patients with significant depression, an antidepressant is more likely to succeed than a benzodiazepine. Generalized anxiety disorder is a chronic illness that requires long-term treatment. Remission is attainable but can take several months, and stopping medication increases the risk of relapse within the first year of initiating treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DSM-III-R Generalized Anxiety Disorder in the National Comorbidity Survey
Wittchen, H.-U. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050015002 · Cited by 967
Wang, P. S., Berglund, P., & Kessler, R. C. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.9908044.x · Cited by 686
Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders
FAVA, G. A., RAFANELLI, C., CAZZARO, M., CONTI, S., & GRANDI, S. (1998) · Psychological Medicine · doi:10.1017/s0033291797006363 · Cited by 427 · cited 1×
“There is some evidence that well-being therapy, which emphasizes the constructs of positive psychology and building of resilience, is superior to regular CBT in patients with anxiety, including GAD, who have shown only a partial response to first-line treatment.(45) Such approaches offer considerable promise as a form…”
Well-Being Therapy of Generalized Anxiety Disorder
Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Salmaso, L., Mangelli, L., & Sirigatti, S. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000082023 · Cited by 344 · cited 1×
“In 1 randomized controlled trial, well-being therapy with CBT was superior to CBT alone in GAD when followed over a long period.(47)”
Bandelow, B., Chouinard, G., Bobes, J., Ahokas, A., Eggens, I., Liu, S., & Eriksson, H. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990423 · Cited by 142
Fava, G. A., Ruini, C., Rafanelli, C., & Grandi, S. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2094 · Cited by 88 · cited 1×
“This form of therapy may also serve those who relapse while on antidepressant drugs for depression.(46) In 1 randomized controlled trial, well-being therapy with CBT was superior to CBT alone in GAD when followed over a long period.”
Psychopharmacologic Treatment of Generalized Anxiety Disorder and the Risk of Major Depression
Goodwin, R. D., & Gorman, J. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1935 · Cited by 49
Cited by
Anxiety and Risk of Incident Coronary Heart Disease
Roest, A. M., Martens, E. J., de Jonge, P., & Denollet, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.034 · Cited by 865
Treatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 284
Hydroxyzine for generalised anxiety disorder
Guaiana, G., Barbui, C., & Cipriani, A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006815.pub2 · Cited by 272
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
Richardson-Jones, J. W., Craige, C. P., Nguyen, T. H., Kung, H. F., Gardier, A. M., Dranovsky, A., David, D. J., Guiard, B. P., Beck, S. G., Hen, R., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5836-10.2011 · Cited by 192
Roest, A. M., de Jonge, P., Williams, C. D., de Vries, Y. A., Schoevers, R. A., & Turner, E. H. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.15 · Cited by 101
Rickels, K., Etemad, B., Khalid-Khan, S., Lohoff, F. W., Rynn, M. A., & Gallop, R. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.170 · Cited by 63
Advances in the management of treatment-resistant anxiety disorders
Lanouette, N. M., & Stein, M. B. (2010) · Focus · doi:10.1176/foc.8.4.foc501 · Cited by 15
Metadata
- Authors
- Davidson, J. R. T.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2009-04
- Volume
- 70
- Issue
- suppl 2
- Pages
- 25-31
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2013635412
- Cited by
- 69
- References
- 7
- Type
- conference abstract
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.